Conditions: Benign Prostatic Hyperplasia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 61
Healthy volunteers: no

Brief summary:
This is a 24 week study evaluating the effects of botulinum toxin Type A on semen quality in patients with signs and symptoms of Benign Prostatic Hyperplasia (BPH).

Detailed description:

Arms:
arm 1: OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1. arm 2: Placebo (saline) injected into the prostate on Day 1.

Interventions: intervention 1: Botulinum Toxin Type A intervention 2: Placebo (saline)
Intervention descriptions: intervention 1: OnabotulinumtoxinA (botulinum toxin Type A) 200U injected into the prostate on Day 1. intervention 2: Saline injected into the prostate on Day 1.

Protocol document: